CTSO
Cytosorbents Crp
3.90$
-2.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +71.3% | -44.1% | +0.7% | -4.0% | -0.7% | -4.9% | +8.8% | -8.9% | -4.0% | -2.3% | +0.0% | – | |
| – | -22.2% | -8.9% | -12.7% | -41.9% | +210.6% | -45.8% | -30.0% | -14.8% | +198.9% | -62.7% | +67.6% | – | |
| – | -55.7% | -2,352.7% | – | – | -219.1% | – | – | -158.4% | – | – | +126.9% | – | |
| – | -47.3% | -6.6% | -5.6% | +148.9% | -58.4% | -62.0% | -21.9% | -53.9% | +269.9% | -82.5% | +127.3% | – | |
| – | -47.3% | -6.6% | -6.3% | +150.8% | -58.4% | -62.0% | +178.9% | – | -629.1% | -84.2% | -15.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,783.4% | -104.7% | – | -101.0% | – | +3,994.5% | -100.0% | -100.0% | – | -100.0% | – | – | |
| – | – | -195.7% | – | – | – | – | -141.3% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.